These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


192 related items for PubMed ID: 14726179

  • 21. Antibodies to commercially available interferon-beta molecules in multiple sclerosis patients treated with natural interferon-beta.
    Mayorga C, Luque G, Romero F, Guerrero R, Blanca M, Fernandez O.
    Int Arch Allergy Immunol; 1999; 118(2-4):368-71. PubMed ID: 10224450
    [No Abstract] [Full Text] [Related]

  • 22. Interferon beta preparations for the treatment of multiple sclerosis patients differ in neutralizing antibody seroprevalence and immunogenicity.
    Sominanda A, Rot U, Suoniemi M, Deisenhammer F, Hillert J, Fogdell-Hahn A.
    Mult Scler; 2007 Mar; 13(2):208-14. PubMed ID: 17439886
    [Abstract] [Full Text] [Related]

  • 23. Beta-interferon for multiple sclerosis.
    Rudick RA, Goelz SE.
    Exp Cell Res; 2011 May 15; 317(9):1301-11. PubMed ID: 21396360
    [Abstract] [Full Text] [Related]

  • 24. Neutralising antibodies to interferon beta.
    Ortenzi C.
    J Neurol Neurosurg Psychiatry; 2003 Aug 15; 74(8):1162; author reply 1162-3. PubMed ID: 12876267
    [No Abstract] [Full Text] [Related]

  • 25. Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis.
    Polman CH, Bertolotto A, Deisenhammer F, Giovannoni G, Hartung HP, Hemmer B, Killestein J, McFarland HF, Oger J, Pachner AR, Petkau J, Reder AT, Reingold SC, Schellekens H, Sørensen PS.
    Lancet Neurol; 2010 Jul 15; 9(7):740-50. PubMed ID: 20610349
    [Abstract] [Full Text] [Related]

  • 26. Neutralising antibodies to interferon beta in multiple sclerosis : expert panel report.
    Hartung HP, Polman C, Bertolotto A, Deisenhammer F, Giovannoni G, Havrdova E, Hemmer B, Hillert J, Kappos L, Kieseier B, Killestein J, Malcus C, Comabella M, Pachner A, Schellekens H, Sellebjerg F, Selmaj K, Sorensen PS.
    J Neurol; 2007 Jul 15; 254(7):827-37. PubMed ID: 17457510
    [Abstract] [Full Text] [Related]

  • 27. Prevalence of anti-drug antibodies against interferon beta has decreased since routine analysis of neutralizing antibodies became clinical practice.
    Jungedal R, Lundkvist M, Engdahl E, Ramanujam R, Westerlind H, Sominanda A, Hillert J, Fogdell-Hahn A.
    Mult Scler; 2012 Dec 15; 18(12):1775-81. PubMed ID: 22551640
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort study.
    Jensen PEH, Warnke C, Ingenhoven K, Piccoli L, Gasis M, Hermanrud C, Fernandez-Rodriguez BM, Ryner M, Kramer D, Link J, Ramanujam R, Auer M, Buck D, Grummel V, Bertotti E, Fissolo N, Oliver-Martos B, Nytrova P, Khalil M, Guger M, Rathmaier S, Sievers-Stober C, Lindberg RLP, Hässler S, Bachelet D, Aktas O, Donnellan N, Lawton A, Hemmer B, Havrdova EK, Kieseier B, Hartung HP, Comabella M, Montalban X, Derfuss T, Sellebjerg F, Dönnes P, Pallardy M, Spindeldreher S, Broët P, Deisenhammer F, Fogdell-Hahn A, Sorensen PS, ABIRISK Consortium.
    J Neuroimmunol; 2019 Jan 15; 326():19-27. PubMed ID: 30447419
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.